Arbutus Biopharma (ABUS)
(Delayed Data from NSDQ)
$3.35 USD
+0.06 (1.82%)
Updated May 28, 2024 04:00 PM ET
After-Market: $3.35 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Arbutus Biopharma Corporation [ABUS]
Reports for Purchase
Showing records 161 - 180 ( 190 total )
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
Biopharmaceuticals - The Road Is Long, but We Have Taken the First Steps - Takeaways on HBV from the Liver Meeting
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
Arbutus Reports 3Q16 Ahead of AASLD; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences - Upcoming Events for the Week of Oct 10
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
Biotechnology - Progress Continues Forward with HDV and HBV Therapies - AASLD Abstract Takeaways
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
Progress Continues Forward with HDV and HBV Therapies - AASLD Abstract Takeaways
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
First Glimpse of Efficacy Suggests Potential for ARB-1467; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences: Upcoming Events for the Week of September 26
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
First Look at ARB-1467 in HBV Patients Next Week - What Should We Expect?; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences: Upcoming Events for the Week of August 29
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
Reports 2Q16 Ahead of First Efficacy Read of ARB- 1467 in HBV Patients
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences: Upcoming Events for the Week of August 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences: Upcoming Events for the Week of July 25
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
TKM-PLK1 Data Supportive of Arbutus Platform; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences: Upcoming Events for the Week of July 18
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences: Upcoming Events for the Week of June 27
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
Reports 1Q16 Financial Results; RNAi Data to Come this Year; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
A Suite of Mechanisms Under One Roof Help Plot a Forward Path; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
Company: Arbutus Biopharma Corporation
Industry: Medical - Biomedical and Genetics
Arbutus Reports FY15 as it Moves its Pipeline Forward;Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: BEHANNA H